University of Pittsburgh, Department of Medicine.
Pittsburgh, Pennsylvania, 15232, United States
NCT Number: NCT02770781
The purpose is to examine the feasibility and preliminary effectiveness of the role of a personal trainer for non-metastatic breast cancer survivors to improve physical activity and well-being (in terms of quality of life).
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Pittsburgh, Pennsylvania, 15232, United States
After breast cancer treatment, many women are faced with effects of treatment such as changes in appearance, fatigue, and reduced quality of life as compared to the pre-disease state. An intervention to increase physical activity may be helpful to improve well-being and outcomes for women treated for breast cancer.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will receive a personal exercise regimen based on their health history and individual capability.
Time frame: Baseline through ~ 6 months of follow-up.
Pilot study
Time frame: Baseline through ~ 6 months of follow-up.
Measured by pedometer.
Time frame: Baseline and ~ 6 months
This questionnaire asks about exercise habits.
Time frame: Baseline and ~ 6 months
This questionnaire will measure a person's perceived competence to engage in an activity
Time frame: Baseline and ~ 6 months
This is a quality of life questionnaire
University of Pittsburgh
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00006421
Breast Cancer, Breast Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05898009
BRCA2 Mutation, Breast Cancer
Saint-Pierre, France
View Trial DetailsNCT03667612
Breast Cancer, Breast Diseases
Lille, France
View Trial DetailsNCT05206331
Breast Cancer, Breast Diseases
Pittsburgh, Pennsylvania, United States
View Trial Details